首页 > 最新文献

International Journal of Surgery-Oncology最新文献

英文 中文
The top 100 most-cited articles on osteosarcoma: a bibliometric analysis 关于骨肉瘤的100篇被引用次数最多的文章:文献计量学分析
IF 0.3 Pub Date : 2018-05-01 DOI: 10.1097/IJ9.0000000000000062
M. Hafeez, A. Malik, Shahryar Noordin
Background: Osteosarcoma or “osteogenic sarcoma” is the most common neoplasm of the bone in children and young adults. This research is premised upon a citation analysis of the top 100 most-cited articles on osteosarcoma. Materials and Methods: This research is dependent upon the use of SCOPUS database. Using the search strategy “osteosarcoma” on this database yielded 12,107 articles. After filtering for relevant articles, the top 100 most-cited articles were retrieved for descriptive and statistical analysis. Results: The most-cited paper was “A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma” by Friend and colleagues published in 1986 with 1888 citations. The publication years ranged from 1967 to 2014. The United States was the most productive country in terms of research output, followed by Italy. Institution-wise, the Memorial Sloan-Kettering Cancer Centre contributed the most articles. However, the most prolific author was from Italy. Majority of the publications were level IV studies Conclusions: Although citation analysis is not entirely flawless, this is a comprehensive list of the top 100 most-cited articles significantly impacting osteosarcoma knowledge and research over time. Future studies need to cater toward maximizing high-quality evidenced articles.
背景:骨肉瘤或“成骨肉瘤”是儿童和年轻人中最常见的骨肿瘤。本研究的前提是对骨肉瘤前100篇被引用次数最多的文章进行引文分析。材料和方法:本研究依赖于SCOPUS数据库的使用。使用搜索策略“骨肉瘤”在这个数据库中产生了12107篇文章。过滤相关文章后,检索前100篇被引用最多的文章进行描述性和统计分析。结果:被引用最多的论文是Friend及其同事于1986年发表的《具有视网膜母细胞瘤和骨肉瘤易感性基因特性的人类DNA片段》,被引用1888次。出版年份从1967年到2014年。就研究产出而言,美国是生产率最高的国家,其次是意大利。在机构方面,纪念斯隆-凯特琳癌症中心贡献了最多的文章。然而,最多产的作家来自意大利。结论:虽然引文分析并非完全完美,但这是一份全面的前100篇被引用次数最多的文章列表,这些文章随着时间的推移对骨肉瘤知识和研究产生了重大影响。未来的研究需要迎合高质量证据文章的最大化。
{"title":"The top 100 most-cited articles on osteosarcoma: a bibliometric analysis","authors":"M. Hafeez, A. Malik, Shahryar Noordin","doi":"10.1097/IJ9.0000000000000062","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000062","url":null,"abstract":"Background: Osteosarcoma or “osteogenic sarcoma” is the most common neoplasm of the bone in children and young adults. This research is premised upon a citation analysis of the top 100 most-cited articles on osteosarcoma. Materials and Methods: This research is dependent upon the use of SCOPUS database. Using the search strategy “osteosarcoma” on this database yielded 12,107 articles. After filtering for relevant articles, the top 100 most-cited articles were retrieved for descriptive and statistical analysis. Results: The most-cited paper was “A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma” by Friend and colleagues published in 1986 with 1888 citations. The publication years ranged from 1967 to 2014. The United States was the most productive country in terms of research output, followed by Italy. Institution-wise, the Memorial Sloan-Kettering Cancer Centre contributed the most articles. However, the most prolific author was from Italy. Majority of the publications were level IV studies Conclusions: Although citation analysis is not entirely flawless, this is a comprehensive list of the top 100 most-cited articles significantly impacting osteosarcoma knowledge and research over time. Future studies need to cater toward maximizing high-quality evidenced articles.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"29 1","pages":"e62"},"PeriodicalIF":0.3,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73599093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Evaluation of different treatment and management options for chondrosarcoma; the prognostic factors determining the outcome of the disease 软骨肉瘤不同治疗和管理方案的评价决定疾病结局的预后因素
IF 0.3 Pub Date : 2018-02-01 DOI: 10.1097/IJ9.0000000000000058
K. Abbas, A. Siddiqui
Importance: This review provides an in-depth discussion of the different treatment and management strategies adopted for chondrosarcoma, the various outcomes and the prognostic factors of the disease. Chondrosarcoma is the third most common malignant bone tumor after myeloma and osteosarcoma. It is characterized by the production of a cartilaginous matrix by malignant cells. It can be classified according to the source of its origin, histopathologic grade, site of occurrence, and rarity. Chondrosarcomas that are de novo in nature are classified as primary chondrosarcomas, while those derived from pre-existing enchondromas or osteochondromas are regarded as secondary chondrosarcomas. Other rare forms of chondrosarcoma include dedifferentiated, mesenchymal, and clear cell chondrosarcomas. Observations/Findings: Early diagnosis, accurate interpretation of histopathology, precise grading, and careful localization are crucial in the management of chondrosarcoma. Surgery is the treatment of choice. Three forms of surgical interventions are present; curettage, radical resection, and amputation. The choice of procedure depends on the size and site of the lesion and degree of malignancy. Radical procedures give the most promising outcomes with wider margins yielding better prognosis. Recurrence is usually seen with delayed surgery, high histopathologic grading, inadequate surgical procedures, marginal excision or curettage, tumor present in inaccessible sites such as sacrum and metastasis. Conclusion: Chondrosarcoma is responsible for placing a significant burden on pediatric as well as adult orthopedic oncology. Optimum diagnosis, accurate interpretation of histopathology, precise grading, careful localization, and timely as well as adequate management is crucial to successfully manage and prevent recurrence of the disease. Surgery is the most effective form of treatment. The main goal of treatment and management is to keep well ahead of the growth of the neoplasm and to prevent recurrences.
重要性:这篇综述深入讨论了软骨肉瘤的不同治疗和管理策略,各种结果和疾病的预后因素。软骨肉瘤是继骨髓瘤和骨肉瘤之后第三常见的恶性骨肿瘤。它的特点是由恶性细胞产生软骨基质。它可以根据其起源来源、组织病理分级、发生部位和罕见度进行分类。本质上新生的软骨肉瘤被归类为原发性软骨肉瘤,而来源于已有的软骨瘤或骨软骨瘤的软骨肉瘤被视为继发性软骨肉瘤。其他罕见形式的软骨肉瘤包括去分化、间充质和透明细胞软骨肉瘤。观察/发现:早期诊断、准确的组织病理学解释、精确的分级和仔细的定位对软骨肉瘤的治疗至关重要。手术是治疗的首选。目前有三种形式的手术干预;刮除,根治性切除和截肢。手术的选择取决于病变的大小、部位和恶性程度。根治性手术的结果最有希望,手术范围更广,预后更好。复发通常见于延迟手术、高组织病理学分级、不适当的外科手术、边缘切除或刮除、肿瘤出现在骶骨等难以接近的部位和转移。结论:软骨肉瘤是儿童和成人骨科肿瘤的重要负担。最佳的诊断,准确的组织病理学解释,精确的分级,仔细定位,及时和充分的管理是成功管理和预防疾病复发的关键。手术是最有效的治疗方法。治疗和管理的主要目标是保持肿瘤的生长和防止复发。
{"title":"Evaluation of different treatment and management options for chondrosarcoma; the prognostic factors determining the outcome of the disease","authors":"K. Abbas, A. Siddiqui","doi":"10.1097/IJ9.0000000000000058","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000058","url":null,"abstract":"Importance: This review provides an in-depth discussion of the different treatment and management strategies adopted for chondrosarcoma, the various outcomes and the prognostic factors of the disease. Chondrosarcoma is the third most common malignant bone tumor after myeloma and osteosarcoma. It is characterized by the production of a cartilaginous matrix by malignant cells. It can be classified according to the source of its origin, histopathologic grade, site of occurrence, and rarity. Chondrosarcomas that are de novo in nature are classified as primary chondrosarcomas, while those derived from pre-existing enchondromas or osteochondromas are regarded as secondary chondrosarcomas. Other rare forms of chondrosarcoma include dedifferentiated, mesenchymal, and clear cell chondrosarcomas. Observations/Findings: Early diagnosis, accurate interpretation of histopathology, precise grading, and careful localization are crucial in the management of chondrosarcoma. Surgery is the treatment of choice. Three forms of surgical interventions are present; curettage, radical resection, and amputation. The choice of procedure depends on the size and site of the lesion and degree of malignancy. Radical procedures give the most promising outcomes with wider margins yielding better prognosis. Recurrence is usually seen with delayed surgery, high histopathologic grading, inadequate surgical procedures, marginal excision or curettage, tumor present in inaccessible sites such as sacrum and metastasis. Conclusion: Chondrosarcoma is responsible for placing a significant burden on pediatric as well as adult orthopedic oncology. Optimum diagnosis, accurate interpretation of histopathology, precise grading, careful localization, and timely as well as adequate management is crucial to successfully manage and prevent recurrence of the disease. Surgery is the most effective form of treatment. The main goal of treatment and management is to keep well ahead of the growth of the neoplasm and to prevent recurrences.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"23 1","pages":"e58"},"PeriodicalIF":0.3,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83981444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Neoadjuvant chemotherapy and the complexity of operative procedure in advanced epithelial ovarian cancer: a retrospective analysis 晚期上皮性卵巢癌的新辅助化疗与手术复杂性:回顾性分析
IF 0.3 Pub Date : 2018-02-01 DOI: 10.1097/IJ9.0000000000000059
B. Refky, Amr F. Elalfy, H. Nabil, D. El-Emam, K. Abdelwahab, E. Malik, A. Soliman
Introduction: Complete tumor resection for epithelial ovarian cancer (EOC) generally incorporates complex surgical maneuvers, especially bowel resection. This study retrospectively analyzed the impact of neoadjuvant chemotherapy (NAC) on complexity of surgical procedures for EOC (represented by bowel resection) and postoperative morbidity. Methods: We retrospectively recruited all patients with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stages IIIC–IVB EOC who were treated in our center between 2011 and 2016. Patients were divided into those who received primary debulking followed by chemotherapy (group A), and those who received NAC followed by interval debulking (group B). Patient age, tumor stage, grade, dates of commencement and completion of therapy, intraoperative events, completion of surgical resection, and postoperative events were evaluated. Results: Of 92 patients, 42 were assigned to group A and 50 to group B. Their FIGO stages were group A—stages IIIC: 34 (80.9%), IVA: 6 (14.3%), and IVB: 2 (4.8%); and group B—stages IIIC: 45 (90%), IVA: 5 (10%), and IVB: 0 (0%). The 2 groups did not significantly differ in completeness of surgical cytoreduction or rates of bowel resection, intraoperative complications, or postoperative morbidities. Conclusion: NAC did not reduce rates of bowel resection, intraoperative complications, and postoperative morbidity in advanced EOC compared with primary surgical cytoreduction. Future prospective studies will be required to corroborate our results.
上皮性卵巢癌(EOC)的完全肿瘤切除术通常包括复杂的手术操作,特别是肠切除术。本研究回顾性分析了新辅助化疗(NAC)对EOC手术程序复杂性(以肠切除术为代表)和术后发病率的影响。方法:回顾性招募2011年至2016年在我中心治疗的所有患有fidic - iii - ivb期EOC的患者。患者分为先行减容后化疗组(A组)和先行NAC后间歇减容组(B组)。对患者年龄、肿瘤分期、分级、开始和完成治疗的日期、术中事件、手术切除完成和术后事件进行评估。结果:92例患者中,A组42例,b组50例,FIGO分期为A组IIIC: 34例(80.9%),IVA: 6例(14.3%),IVB: 2例(4.8%);b组IIIC: 45例(90%),IVA: 5例(10%),IVB: 0例(0%)。两组在手术细胞减少的完全性、肠切除术的发生率、术中并发症或术后发病率方面没有显著差异。结论:与最初的手术细胞减少术相比,NAC并没有降低晚期EOC的肠切除率、术中并发症和术后发病率。未来的前瞻性研究将需要证实我们的结果。
{"title":"Neoadjuvant chemotherapy and the complexity of operative procedure in advanced epithelial ovarian cancer: a retrospective analysis","authors":"B. Refky, Amr F. Elalfy, H. Nabil, D. El-Emam, K. Abdelwahab, E. Malik, A. Soliman","doi":"10.1097/IJ9.0000000000000059","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000059","url":null,"abstract":"Introduction: Complete tumor resection for epithelial ovarian cancer (EOC) generally incorporates complex surgical maneuvers, especially bowel resection. This study retrospectively analyzed the impact of neoadjuvant chemotherapy (NAC) on complexity of surgical procedures for EOC (represented by bowel resection) and postoperative morbidity. Methods: We retrospectively recruited all patients with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stages IIIC–IVB EOC who were treated in our center between 2011 and 2016. Patients were divided into those who received primary debulking followed by chemotherapy (group A), and those who received NAC followed by interval debulking (group B). Patient age, tumor stage, grade, dates of commencement and completion of therapy, intraoperative events, completion of surgical resection, and postoperative events were evaluated. Results: Of 92 patients, 42 were assigned to group A and 50 to group B. Their FIGO stages were group A—stages IIIC: 34 (80.9%), IVA: 6 (14.3%), and IVB: 2 (4.8%); and group B—stages IIIC: 45 (90%), IVA: 5 (10%), and IVB: 0 (0%). The 2 groups did not significantly differ in completeness of surgical cytoreduction or rates of bowel resection, intraoperative complications, or postoperative morbidities. Conclusion: NAC did not reduce rates of bowel resection, intraoperative complications, and postoperative morbidity in advanced EOC compared with primary surgical cytoreduction. Future prospective studies will be required to corroborate our results.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"38 1","pages":"e59"},"PeriodicalIF":0.3,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76121006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of extent and completeness of mesorectal excision for rectal cancer by histopathology and MRI 用组织病理学和MRI评估直肠癌肠系膜切除的程度和完整性
IF 0.3 Pub Date : 2018-02-01 DOI: 10.1097/IJ9.0000000000000053
T. Hassan, F. Parray, Zubaida Rasool, N. Chowdri, F. Shaheen, R. Wani
Introduction: High quality of total mesorectal excision (TME) surgical technique and critical feedback regarding its completeness by pathologist and a radiologist has been shown to influence the quality of surgery in patients with rectal cancer. In this study, we tried to audit the quality of TME by 2 independent observers, a consultant pathologist and radiologist. TME was performed for all patients with rectal tumors located <12 cm from the anal verge. Main Outcome Measures: TME specimens were examined for completeness by experienced single consultant pathologist to avoid interobserver bias. Postoperatively magnetic resonance imaging was done that was interpreted by a single consultant radiologist to avoid interobserver bias in the study. Discussion: Of total 103 patients, TME assessment was done in 53 patients. TME was complete in 35 cases (66%), near complete in 14 cases (26%), and incomplete in 4 cases (8%) (P<0.05). Twenty-eight cases were subjected to radiologic assessment of TME. Complete TME was found in 19 (67%) and residual mesorectum was found in 9 (32%). The radiologic findings co-related with pathology findings in these 28 cases as 17 cases were confirmed TME complete by both magnetic resonance imaging and histopathology, 4 cases were confirmed incomplete by both and out of 7 near complete TME by pathology, 2 were labeled as complete on radiology while 5 were labeled as incomplete (P<0.05). Seven (13.2%) cases had positive circumferential resection margin. Distal resection margin was >2 cm in about 81.1%, <2 cm in 15% and involved in 3.7% of cases. The lymph node yield was of 4–21 with an average of 11.5 nodes; with 54.7% having adequate nodal harvest (>12 lymph nodes). Conclusions: Pathologist’s and radiologist’s constructive criticism will always help a surgeon to improve his quality of TME.
导读:高质量的全肠系膜切除(TME)手术技术和病理学家和放射科医生对其完整性的关键反馈已被证明影响直肠癌患者的手术质量。在这项研究中,我们试图通过2个独立的观察员,一个咨询病理学家和放射科医生来审核TME的质量。所有直肠肿瘤位于2cm(约81.1%,12个淋巴结)的患者均行TME。结论:病理和放射科医师的建设性批评有助于外科医生提高TME手术质量。
{"title":"Assessment of extent and completeness of mesorectal excision for rectal cancer by histopathology and MRI","authors":"T. Hassan, F. Parray, Zubaida Rasool, N. Chowdri, F. Shaheen, R. Wani","doi":"10.1097/IJ9.0000000000000053","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000053","url":null,"abstract":"Introduction: High quality of total mesorectal excision (TME) surgical technique and critical feedback regarding its completeness by pathologist and a radiologist has been shown to influence the quality of surgery in patients with rectal cancer. In this study, we tried to audit the quality of TME by 2 independent observers, a consultant pathologist and radiologist. TME was performed for all patients with rectal tumors located <12 cm from the anal verge. Main Outcome Measures: TME specimens were examined for completeness by experienced single consultant pathologist to avoid interobserver bias. Postoperatively magnetic resonance imaging was done that was interpreted by a single consultant radiologist to avoid interobserver bias in the study. Discussion: Of total 103 patients, TME assessment was done in 53 patients. TME was complete in 35 cases (66%), near complete in 14 cases (26%), and incomplete in 4 cases (8%) (P<0.05). Twenty-eight cases were subjected to radiologic assessment of TME. Complete TME was found in 19 (67%) and residual mesorectum was found in 9 (32%). The radiologic findings co-related with pathology findings in these 28 cases as 17 cases were confirmed TME complete by both magnetic resonance imaging and histopathology, 4 cases were confirmed incomplete by both and out of 7 near complete TME by pathology, 2 were labeled as complete on radiology while 5 were labeled as incomplete (P<0.05). Seven (13.2%) cases had positive circumferential resection margin. Distal resection margin was >2 cm in about 81.1%, <2 cm in 15% and involved in 3.7% of cases. The lymph node yield was of 4–21 with an average of 11.5 nodes; with 54.7% having adequate nodal harvest (>12 lymph nodes). Conclusions: Pathologist’s and radiologist’s constructive criticism will always help a surgeon to improve his quality of TME.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"6 1","pages":"e53"},"PeriodicalIF":0.3,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77013911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Peer review in scholarly publishing part B: how to do it? 学术出版中的同行评议:如何做?
IF 0.3 Pub Date : 2018-01-01 DOI: 10.1097/IJ9.0000000000000055
A. Fowler, K. Koshy, B. Gundogan, R. Agha
Peer review is a key part of the scientific process, whereby a body of experts review a manuscript and provide feedback. In this article, we discuss the steps typically undertaken in completing a peer review and key questions to be asked of the manuscript while undertaking a review. This article provides a step-by-step instructional guide in how to effectively peer review a paper.
同行评议是科学过程的关键部分,由一组专家评议稿件并提供反馈。在本文中,我们讨论了完成同行评审的典型步骤,以及在进行评审时要问的手稿的关键问题。本文提供了一个循序渐进的指导,教你如何有效地对论文进行同行评审。
{"title":"Peer review in scholarly publishing part B: how to do it?","authors":"A. Fowler, K. Koshy, B. Gundogan, R. Agha","doi":"10.1097/IJ9.0000000000000055","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000055","url":null,"abstract":"Peer review is a key part of the scientific process, whereby a body of experts review a manuscript and provide feedback. In this article, we discuss the steps typically undertaken in completing a peer review and key questions to be asked of the manuscript while undertaking a review. This article provides a step-by-step instructional guide in how to effectively peer review a paper.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"44 1","pages":"e55"},"PeriodicalIF":0.3,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73294175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excision of mucinous cystadenoma of pancreas is safe and effective: a case report 胰腺粘液囊腺瘤切除术安全有效1例
IF 0.3 Pub Date : 2018-01-01 DOI: 10.1097/IJ9.0000000000000047
E. Weledji, Divine Eyongetah, T. Nana, M. Ngowe
Background: Pancreatic cysts are frequently detected incidentally, and a definitive preoperative diagnosis remains challenging. Benign cystic lesions have a very high cure rate unless malignant change supervenes. Simple excision of benign cysts of the pancreas is safe and effective. Case presentation: We present a 31-year-old woman with a 3-year history of an enlarging symptomatic benign pancreatic mucinous cystadenoma, which was misdiagnosed radiologically as a pancreatic serous cystadenoma or a mesenteric cyst. This was managed safely by excision and resection with a distal pancreatectomy that was avoided. Conclusions: Excision of benign mucinous cystadenoma of the pancreas is safe and effective, and surveillance for recurrence is not necessary.
背景:胰腺囊肿经常是偶然发现的,明确的术前诊断仍然具有挑战性。良性囊性病变有很高的治愈率,除非发生恶性改变。单纯切除良性胰腺囊肿是安全有效的。病例介绍:我们报告一位31岁的女性,她有3年的扩大症状性良性胰腺粘液囊腺瘤病史,放射学上误诊为胰腺浆液性囊腺瘤或肠系膜囊肿。这是安全管理的切除和切除远端胰腺切除术是避免的。结论:胰腺良性粘液囊腺瘤切除术是安全有效的,无需监测复发。
{"title":"Excision of mucinous cystadenoma of pancreas is safe and effective: a case report","authors":"E. Weledji, Divine Eyongetah, T. Nana, M. Ngowe","doi":"10.1097/IJ9.0000000000000047","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000047","url":null,"abstract":"Background: Pancreatic cysts are frequently detected incidentally, and a definitive preoperative diagnosis remains challenging. Benign cystic lesions have a very high cure rate unless malignant change supervenes. Simple excision of benign cysts of the pancreas is safe and effective. Case presentation: We present a 31-year-old woman with a 3-year history of an enlarging symptomatic benign pancreatic mucinous cystadenoma, which was misdiagnosed radiologically as a pancreatic serous cystadenoma or a mesenteric cyst. This was managed safely by excision and resection with a distal pancreatectomy that was avoided. Conclusions: Excision of benign mucinous cystadenoma of the pancreas is safe and effective, and surveillance for recurrence is not necessary.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"23 1","pages":"e47"},"PeriodicalIF":0.3,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73194617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Peer review in scholarly publishing part A: why do it? 学术出版中的同行评议:为什么要这样做?
IF 0.3 Pub Date : 2018-01-01 DOI: 10.1097/IJ9.0000000000000056
K. Koshy, A. Fowler, B. Gundogan, R. Agha
Peer review is a process whereby scientific experts evaluate a manuscript and provide feedback, offering a recommendation of whether the work is suitable for publication. In this article, we discuss the principles behind peer review and the different forms that it can take. We discuss the importance of peer reviewing, its drawbacks and the reasons an individual may want to become a peer reviewer.
同行评议是科学专家评估稿件并提供反馈的过程,就该作品是否适合发表提出建议。在本文中,我们将讨论同行评审背后的原则以及它可能采取的不同形式。我们讨论了同行评议的重要性,它的缺点和个人可能想成为同行评议的原因。
{"title":"Peer review in scholarly publishing part A: why do it?","authors":"K. Koshy, A. Fowler, B. Gundogan, R. Agha","doi":"10.1097/IJ9.0000000000000056","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000056","url":null,"abstract":"Peer review is a process whereby scientific experts evaluate a manuscript and provide feedback, offering a recommendation of whether the work is suitable for publication. In this article, we discuss the principles behind peer review and the different forms that it can take. We discuss the importance of peer reviewing, its drawbacks and the reasons an individual may want to become a peer reviewer.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"45 1","pages":"e56"},"PeriodicalIF":0.3,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73790122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Early complications in cases series in implant-based immediate breast reconstruction with a biological acellular matrix during the learning curve of this technique and using 3 different matrices: a case series of 84 breasts 生物脱细胞基质植体即刻乳房再造术的早期并发症及3种不同基质的使用:84个乳房
IF 0.3 Pub Date : 2017-12-01 DOI: 10.1097/IJ9.0000000000000052
J. Aguilera-Sáez, P. Bosacoma Roura, Anselmo Garrido Ferrer, A. Guinot Madridejos, J. Barret
Introduction: We present our experience in implant-based immediate breast reconstruction (IBIBR) with biological acellular matrix during our learning curve and compare the complications with the use of three different matrices. Materials and methods: We did a retrospective study on patients who underwent an IBIBR with acellular matrix after skin sparing mastectomy with or without nipple-areolar complex preservation at the Breast Pathology Unit at University Hospital Vall d’Hebron, Barcelona (Spain) between July 2011 and December 2014. Results: A total of 84 breasts were reconstructed in 71 women. A therapeutic mastectomy was performed in 55 of them (65.5%) and a prophylactic mastectomy in 29 (34.5%). The total rate of complications was 41.67% (35 patients): we found 11 cases of erythema (13.1%), 19 cases of seroma (22.62%), 9 cases of hematoma (10.71%), 17 cases of wound dehiscence (20.24%), 11 cases of skin flap necrosis (13.1%), and 10 cases of reconstruction failure (11.9%). The probability of reconstruction failure was higher in smokers and former smokers (P=0.0011%). There were more complications with the Protexa matrix than with the other 2, Strattice and Tutomesh (P<0.001) and a higher risk of reconstruction failure as well (P=0.03). Conclusions: In our experience the use of acellular matrix in IBIBR can have a high rate of complications, especially during the learning curve. Therefore, the selection of suitable patients and the better matrix is an issue of great importance to achieve favorable results.
简介:在我们的学习曲线中,我们介绍了使用生物脱细胞基质进行植入式即刻乳房重建(IBIBR)的经验,并比较了使用三种不同基质的并发症。材料和方法:我们对2011年7月至2014年12月在西班牙巴塞罗那Vall d 'Hebron大学医院乳腺病理科进行的保留皮肤乳房切除术(有或没有保留乳头-乳晕复体)后行脱细胞基质IBIBR的患者进行了回顾性研究。结果:71例患者共行84个乳房再造术。其中治疗性乳房切除术55例(65.5%),预防性乳房切除术29例(34.5%)。并发症发生率为41.67%(35例),其中红斑11例(13.1%),血肿19例(22.62%),血肿9例(10.71%),创面裂开17例(20.24%),皮瓣坏死11例(13.1%),重建失败10例(11.9%)。吸烟者和已戒烟者重建失败的概率较高(P=0.0011%)。与Strattice和Tutomesh相比,Protexa基质的并发症更多(P<0.001),重建失败的风险也更高(P=0.03)。结论:根据我们的经验,在IBIBR中使用脱细胞基质可能有很高的并发症发生率,特别是在学习曲线期间。因此,选择合适的患者和更好的基质是一个非常重要的问题,以取得良好的效果。
{"title":"Early complications in cases series in implant-based immediate breast reconstruction with a biological acellular matrix during the learning curve of this technique and using 3 different matrices: a case series of 84 breasts","authors":"J. Aguilera-Sáez, P. Bosacoma Roura, Anselmo Garrido Ferrer, A. Guinot Madridejos, J. Barret","doi":"10.1097/IJ9.0000000000000052","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000052","url":null,"abstract":"Introduction: We present our experience in implant-based immediate breast reconstruction (IBIBR) with biological acellular matrix during our learning curve and compare the complications with the use of three different matrices. Materials and methods: We did a retrospective study on patients who underwent an IBIBR with acellular matrix after skin sparing mastectomy with or without nipple-areolar complex preservation at the Breast Pathology Unit at University Hospital Vall d’Hebron, Barcelona (Spain) between July 2011 and December 2014. Results: A total of 84 breasts were reconstructed in 71 women. A therapeutic mastectomy was performed in 55 of them (65.5%) and a prophylactic mastectomy in 29 (34.5%). The total rate of complications was 41.67% (35 patients): we found 11 cases of erythema (13.1%), 19 cases of seroma (22.62%), 9 cases of hematoma (10.71%), 17 cases of wound dehiscence (20.24%), 11 cases of skin flap necrosis (13.1%), and 10 cases of reconstruction failure (11.9%). The probability of reconstruction failure was higher in smokers and former smokers (P=0.0011%). There were more complications with the Protexa matrix than with the other 2, Strattice and Tutomesh (P<0.001) and a higher risk of reconstruction failure as well (P=0.03). Conclusions: In our experience the use of acellular matrix in IBIBR can have a high rate of complications, especially during the learning curve. Therefore, the selection of suitable patients and the better matrix is an issue of great importance to achieve favorable results.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"1 1","pages":"e52"},"PeriodicalIF":0.3,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89330908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Cancer immunotherapy in patients with new or recurrent malignancies after liver transplantation. 肝移植术后新发或复发恶性肿瘤患者的肿瘤免疫治疗。
IF 0.3 Pub Date : 2017-12-01 Epub Date: 2017-11-16 DOI: 10.1097/IJ9.0000000000000049
Mengqi Liu, Wenzhi Guo, Shuijun Zhang

Cancer immunotherapy, as a new treatment modality, has been shown to be effective, especially in metastatic melanoma and lung cancer. Organ transplantation can be a life-saving procedure for patients with end-stage diseases of lung, heart, kidney and liver. While ironically, as improvements in organ transplantation have extended patients' lives, new or recurrent postsurgical malignancies have become an increasing threat to their long-term survival, especially in patients after liver transplantation due to hepatocellular carcinoma. The feasibility of immunotherapy treatment for such patients is still to be investigated.

肿瘤免疫治疗作为一种新的治疗方式,已被证明是有效的,特别是在转移性黑色素瘤和肺癌。对于患有肺、心、肾和肝等终末期疾病的患者来说,器官移植可以挽救生命。然而具有讽刺意味的是,随着器官移植技术的进步延长了患者的生命,术后新发或复发的恶性肿瘤却越来越威胁患者的长期生存,尤其是肝移植后因肝细胞癌引起的患者。免疫疗法治疗此类患者的可行性仍有待研究。
{"title":"Cancer immunotherapy in patients with new or recurrent malignancies after liver transplantation.","authors":"Mengqi Liu,&nbsp;Wenzhi Guo,&nbsp;Shuijun Zhang","doi":"10.1097/IJ9.0000000000000049","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000049","url":null,"abstract":"<p><p>Cancer immunotherapy, as a new treatment modality, has been shown to be effective, especially in metastatic melanoma and lung cancer. Organ transplantation can be a life-saving procedure for patients with end-stage diseases of lung, heart, kidney and liver. While ironically, as improvements in organ transplantation have extended patients' lives, new or recurrent postsurgical malignancies have become an increasing threat to their long-term survival, especially in patients after liver transplantation due to hepatocellular carcinoma. The feasibility of immunotherapy treatment for such patients is still to be investigated.</p>","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"2 11","pages":"e49"},"PeriodicalIF":0.3,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/IJ9.0000000000000049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35710559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Evaluation of the antimetastatic and antitumor activity, of antibody loaded pemetrexed nanoparticles, in DEN-HepG2 hepatocarcinoma model 抗体负载培美曲塞纳米颗粒在DEN-HepG2肝癌模型中的抗转移和抗肿瘤活性评价
IF 0.3 Pub Date : 2017-12-01 DOI: 10.1097/IJ9.0000000000000048
S. S. Agrawal, N. Kaushik
Hepatocellular carcinoma (HCC) is the sixth highest incidence of cancer worldwide, accounting for 5.7% of the overall incident cases of cancer with the third leading cause of cancer-related deaths in all age group population. Matrix metalloproteinases play an important role in cancer progression, including tumor growth, invasion, metastasis, and angiogenesis, thus the drug delivery system targeting on MMP’s would be of good significance. This study aims evaluation of the antimetastatic and antitumor activity, of antibody loaded pemetrexed nanoparticles, in di-ethylnitrosamine-HepG2 hepatocarcinoma model. An orthotopic HCC model was prepared by using di-ethylnitrosamine-CCl4 as a precursor for liver cirrhosis and as carcinogen. Study concludes that the HCC model prepared was fast and equivalent to the other models present. The targeted nanoparticles prepared, has better efficacy profile with lower side effects then the free pemetrexed available in market. Low dose and high dose (20/25 mg)/kg of pemetrexed treats HCC significantly. Our results provide a basis for further study of targeted nanoparticles.
肝细胞癌(HCC)是全球发病率第六高的癌症,占癌症总发病率的5.7%,是所有年龄组人口中癌症相关死亡的第三大原因。基质金属蛋白酶在肿瘤的生长、侵袭、转移和血管生成等肿瘤进展过程中发挥着重要作用,因此以基质金属蛋白酶为靶点的药物传递系统具有重要意义。本研究旨在评价抗体负载培美曲塞纳米颗粒在二乙基亚硝胺- hepg2肝癌模型中的抗转移和抗肿瘤活性。以二乙基亚硝胺- ccl4为肝硬化前体和致癌物制备原位肝癌模型。研究表明,所制备的肝细胞癌模型速度快,且与现有的其他肝细胞癌模型相当。所制备的靶向纳米颗粒与市场上的游离培美曲塞相比,具有更好的疗效和更低的副作用。培美曲塞低剂量和高剂量(20/ 25mg)/kg对HCC治疗效果显著。我们的研究结果为进一步研究靶向纳米颗粒提供了基础。
{"title":"Evaluation of the antimetastatic and antitumor activity, of antibody loaded pemetrexed nanoparticles, in DEN-HepG2 hepatocarcinoma model","authors":"S. S. Agrawal, N. Kaushik","doi":"10.1097/IJ9.0000000000000048","DOIUrl":"https://doi.org/10.1097/IJ9.0000000000000048","url":null,"abstract":"Hepatocellular carcinoma (HCC) is the sixth highest incidence of cancer worldwide, accounting for 5.7% of the overall incident cases of cancer with the third leading cause of cancer-related deaths in all age group population. Matrix metalloproteinases play an important role in cancer progression, including tumor growth, invasion, metastasis, and angiogenesis, thus the drug delivery system targeting on MMP’s would be of good significance. This study aims evaluation of the antimetastatic and antitumor activity, of antibody loaded pemetrexed nanoparticles, in di-ethylnitrosamine-HepG2 hepatocarcinoma model. An orthotopic HCC model was prepared by using di-ethylnitrosamine-CCl4 as a precursor for liver cirrhosis and as carcinogen. Study concludes that the HCC model prepared was fast and equivalent to the other models present. The targeted nanoparticles prepared, has better efficacy profile with lower side effects then the free pemetrexed available in market. Low dose and high dose (20/25 mg)/kg of pemetrexed treats HCC significantly. Our results provide a basis for further study of targeted nanoparticles.","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":"31 1","pages":"e48"},"PeriodicalIF":0.3,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87221141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Surgery-Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1